Ira Mellman wants Parker Institute to restore cancer immunotherapy

While the whole world was applauding Revolution Medicines' new cancer drug, all Ira Mellman felt was disappointment and frustration. The pill, daraxonrasib, kept patients with advanced pancreatic cancer alive roughly twice as ...